Advertisement

Pharmacy

Home Pharmacy
More than one-third of advanced melanoma patients were still alive five years after starting therapy with nivolumab (Opdivo)

AACR: Nivolumab Appears to Up Survival in Advanced Melanoma

One-third of study participants lived five years or more after starting treatment

More Dangerous Mouthwashes and Hand Sanitizers Recalled

Hand sanitizer recall due to presence of methanol; oral rinse recall due to possible contamination with bacteria

Users of valsartan contaminated with N-nitrosodimethylamine seem not to have increased cancer risk

No Apparent Short-Term Cancer Risk From Recalled Valsartan

For single cancer outcomes, risk for colorectal, uterine cancer increased, but not significantly so
In patients with telomere diseases

Danazol Treatment Linked to Telomere Elongation

Reduction in rate of telomere attrition at 24 months; gain in telomere length seen from six months
Men receiving 5α-reductase inhibitors have an increased risk for new-onset type 2 diabetes mellitus

Risk for T2DM Increased With Use of 5α-Reductase Inhibitors

Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia
There is a dose-dependent relationship between diagnosis of osteoporosis and statin treatment

Statins Tied to Osteoporosis in Dose-Dependent Manner

Low-dose statins may offer protective effect against osteoporosis
In older adults

Dry Mouth Common Medication Reaction in Older Adults

In intervention studies, greatest risk of dry mouth found with urological medications
Providing an educational handout about influenza disease in the waiting room before a pediatric provider visit may increase receipt of child influenza vaccine

Educational Handout May Increase Receipt of Child Flu Shot

Providing educational intervention in waiting room before pediatric provider visit may be beneficial
The combination of memantine plus sertraline is efficacious for major depressive disorder

Memantine + Sertraline Effective for Major Depressive Disorder

Significantly greater improvement in memantine group; greater response rate at weeks four, six

Improved Meningitis Vaccine May Be On the Way

Advisers are urging the CDC to authorize a vaccine that protects against five types of meningococcal disease